NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
The NSABP-32 trial is a randomized, phase III clinical trial to compare sentinel node (SN) resection to conventional axillary dissection in clinically node-negative breast cancer patients. The primary aims of the trial are to determine if removal of only SNs provides survival and regional control equivalent to those of axillary dissection, while diminishing the magnitude of surgically related side effects. In order to ensure consistency of the outcomes for this trial, a standardized method of SN surgery has been utilized for all cases. A secondary aim of the B32 trial is to evaluate whether patients with “occult” metastases in the SNs have worse survival. Accrual is taking place at 73 institutions in North America, and 217 surgeons are enrolling patients.
- Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie,Lancet 1992;339:1245–8. CrossRef
- Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med 1985;312:674–81. CrossRef
- Hayward JI. The Guy's Hospital trials on breast conservation. In: Silen W, ed.Conservative Management of Breast Cancer: New Surgical and Radiotherapeutic Techniques. Philadelphia: JB Lippincott, 1983:77–90.
- Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer: a report after ten years of a clinical trial.Br. Med J 1972;2:423–9. CrossRef
- Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable cancer of the breast.Br J Surg 1980;67:170–4.
- Johansen H, Kaae S, Schiodt T. Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer: a twenty-five-year follow-up of a randomized trial,Acta Oncol 1990;29:709–15.
- Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis.Ann Surg Oncol 1999;6:109–16. CrossRef
- Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer,N Engl J Med 2002;347:1233–41. CrossRef
- Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials.Lancet 1998;352:930–42. CrossRef
- Bland KI, Scott-Conner CE, Menck H, Winchester DP. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival.J Am Coll Surg 1999;188:586–95; discussion, 595–6. CrossRef
- Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast carcinoma,Surg Gynecol Obstet 1970;131:79–88.
- Osborne M, Ormiston N, Harmer CL, McKinna JA, Baker J, Greening WP. Breast conservation in the treatment of early breast cancer. A 20-year follow-up.Cancer 1984;53:349–55. CrossRef
- NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial
Annals of Surgical Oncology
Volume 11, Issue 3 Supplement, pp 208S-210S
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Breast cancer
- Clinical trial
- Sentinel node
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, College of Medicine, University of Vermont, Given Building E309, 05405, Burlington, VT
- 2. National Surgical Breast and Bowel Project, Pittsburgh, Pennsylvania
- 3. Department of Pathology and Medical Statistics, College of Medicine, University of Vermont, Given Building E309, 05405, Burlington, VT
- 4. Uiversity of Pittsburgh, Pittsburgh, Pennsylvania